Obstacles to Optimal Transitions of Care Between Academic and Community Settings When Utilizing Bispecific Antibodies

EP: 1.Conditions for Administering Bispecific Therapy

EP: 2.Navigating Barriers Which Inhibit Optimal Use of Bispecifics

EP: 3.Key Decision Makers and Contributors Involved In Bispecific Administration

EP: 4.Pain Points In Bispecific Operationalization

EP: 5.Risk Evaluation and Mitigation Strategies [REMS] Program Considerations For Bispecific Therapy

EP: 6.Optimizing Bispecific Use Through EMR Utilization

EP: 7.Best Practices For Uptake and Use of Bispecific Therapy

EP: 8.Achieving Seamless Care Transitions With Patients Receiving Bispecific Therapy

EP: 9.Intro to Bispecific Therapy: Implementation Essentials for Novice Institutions

EP: 10.Key Elements In Monitoring for Potential Adverse Events with Bispecific Antibodies

EP: 11.Protocol For Urgent and Around-the-Clock Bispecific Care

Now Viewing

EP: 12.Obstacles to Optimal Transitions of Care Between Academic and Community Settings When Utilizing Bispecific Antibodies

EP: 13.Managed Care Considerations Within Bispecific Landscape

EP: 14.Payor-Provider Collaboration Driving Optimal Bispecific Therapy Strategies

EP: 15.Medication Assistance Programs Mitigating Financial Burden For Patients Receiving Bispecific Therapy

EP: 16.Bispecific Therapies: Current and Future Considerations

This is a video synopsis/summary of a Peer Exchange involving Ryan Haumschild, PharmD, MS, MBA, CPEL; Kirollos Hanna, PharmD, BCPS, BCOP, FACCC; Sarah Rockwell, PharmD, BCOP; Melody Chang, RPh, MBA, BCOP; and Ryan Cain, PA-C.

Haumschild asks Cain about obstacles to optimal transitions of care between academic and community settings when utilizing bispecific antibodies. Cain identifies time constraints as a key barrier, highlighting the importance of timely consultation and communication around patient urgency when transferring to an academic center. He also notes geographic and financial barriers like long travel distances and limited resources to cover transportation, housing, and other expenses related to seeking care at distant specialized centers. Rural and economically disadvantaged patients may be especially impacted. Cain explains how his group has worked to increase community access to mitigate some of these barriers. He contrasts the robust infrastructure needed to facilitate academic referrals with the streamlined processes enabled by administering bispecific therapies locally. The discussion centers on overcoming obstacles through coordination across care settings to ensure optimal patient transitions.

Video synopsis is AI-generated and reviewed by AJMC® editorial staff.